Indeed, sCD163 levels in the CSF have been shown to be elevated in patients with multiple sclerosis as well as in combination antiretroviral therapy-treated people living with HIV with a mild neurocognitive disorder. The gene discussed is CD163; the disease is multiple sclerosis.